EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Senotherapy preserves resilience in aging

Takumi Mikawa, Kazumichi Yoshida, Hiroshi Kondoh iD

Geriatrics & Gerontology International · 2024

DOI: 10.1111/ggi.14949 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Geriatrics & Gerontology International, 2024. Verfasst von Takumi Mikawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Aging, Senotherapeutics, Cellular Senescence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In aging societies, social and economic burdens of aging‐related diseases are increasing significantly. Senotherapy, which targets aging by eliminating senescent cells (senolytics) or removing sources of chronic inflammation (senostatics), are proposed as novel strategies for aging‐related diseases. Aged or frail people suffer a decline of tissue reserve capacity during aging. Resilience, which is much reduced in older people, is essential for recovery from diseases, stresses or crises. Impaired resilience is one of the reasons why aged people experience a gradual waning of their daily activity and an increase of multimorbidity. Calorie restriction results in senostatic alleviation of chronic inflammation, whereas senolytic drugs induce apoptosis of senescent cells, which exacerbate aging by excreting inflammatory factors. Thus, both senolytics and senostatics are expected to reduce sterile inflammation, originating from senescent cells. Geriatr Gerontol Int 2024; 24: 845–849 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingSenotherapeuticsCellular SenescenceHumansAgedInflammationCaloric Restriction

Stichwörter der Autor:innen

resiliencesenescence‐associated secretor phenotypesenolysissenostaticssenotherapy

Substanzen

Senotherapeutics

Autor:innen und Institutionen

  • Geriatric Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Neurosurgery, Shiga University of Medical Science, Otsu, Japan.

ORCID-Profile: Hiroshi Kondoh

Zitieren

APA

Mikawa, T., Yoshida, K., & Kondoh, H. (2024). Senotherapy preserves resilience in aging. Geriatrics & Gerontology International. https://doi.org/10.1111/ggi.14949

Vancouver

Mikawa T, Yoshida K, Kondoh H. Senotherapy preserves resilience in aging. Geriatrics & Gerontology International. 2024. doi:10.1111/ggi.14949

BibTeX
@article{Mikawa2024,
  author = {Mikawa, Takumi and Yoshida, Kazumichi and Kondoh, Hiroshi},
  title = {Senotherapy preserves resilience in aging},
  journal = {Geriatrics & Gerontology International},
  year = {2024},
  doi = {10.1111/ggi.14949}
}
Kostenlos starten →